5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Special Issue: Environmental Chemistry
12 (
7
); 1290-1297
doi:
10.1016/j.arabjc.2014.10.044

Photocatalysis of β-blockers – An overview

Faculty of Pharmacy, Omar Al-Mukhtar University, Tobruk, Libya
University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, India
Faculty of Pharmacy, Omar Al-Mukhtar University, Al-Beida, Libya
Department of Chemistry, Faculty of Science, Omar Al-Mukhtar University, Tobruk, Libya
Alliance Institute of Advanced Pharmaceutical and Health Sciences, Hyderabad, India

⁎Corresponding author. Tel.: +218 944828805. vkmarothu@gmail.com (Vamsi Krishna Marothu)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

Photocatalysis is one of the most effective advanced oxidation processes to remove residual pharmaceuticals from the aquatic environment. β-Blockers are the group of pharmaceuticals commonly found in the environment and are showing potential risk to the aquatic and terrestrial organisms. This paper provides an overview of different photocatalytic procedures found in the literature for the abatement of β-blockers.

Keywords

Photocatalysis
β-Blockers
Aquatic environment
1

1 Introduction

Beta (β)-blockers are a class of drugs used to treat a variety of cardiovascular diseases, such as hypertension, coronary artery disease and cardiac arrhythmias, by blocking the action of adrenaline and noradrenaline on the β-adrenergic receptors in the body, primarily in the heart (Maurer et al., 2007). The most commonly used β-blockers are atenolol, propranolol and metoprolol, and the structures of those are shown in Fig. 1. Propranolol was the first clinically successful β-blocker developed (De la Cruz et al., 2013) and it has the highest acute and chronic toxicity within the class of β-blockers followed by metoprolol (Christensen et al., 2009; Fent et al., 2006; Maurer et al., 2007).

Chemical structures of (i) atenolol (ii) metoprolol (iii) propranolol.
Figure 1
Chemical structures of (i) atenolol (ii) metoprolol (iii) propranolol.

The presence of active pharmaceutical ingredients (APIs) in the aquatic environments was reported as early in the 1980s (Richardson and Bowron, 1985). It is an emerging environmental issue and provides a new challenge to drinking water, wastewater and water reuse treatment systems (Ikehata et al., 2006). The most important sources of pharmaceutical compounds in the environment are APIs administered to the patient’s excreted either as metabolites or as the unchanged parent compounds, hospitals, pharmaceutical industry waste, and rejected drugs from households, waste water treatment plants and intensive animal breeding farms (Fatta et al., 2007). Pharmaceutical residues have been detected in many environmental matrices worldwide at concentrations ranging from ng/L to μg/L (Benner et al., 2009; Nicolaou et al., 2007; Santos et al., 2009; Ternes and Joss, 2006).This is of great concern in particular because of their potential impact on terrestrial and aquatic ecosystems and public health (Bendz et al., 2005; Cleuvers, 2005; Sharma, 2008).

The occurrence of β-blockers has been repeatedly reported in recent years in the effluents of many wastewater treatment plants around the world (Brun et al., 2006; Carlsson et al., 2009; Conkle et al., 2008; Gabet-Giraud et al., 2010; Huggett et al., 2003; Joakim Larsson and Fick, 2009; Liu and Williams, 2007; Nikolai et al., 2006; Sacher et al., 2001; Ternes, 1998). These compounds are persistent against biological degradation and natural attenuation, and therefore, may remain in the environment for a long time. Conventional wastewater treatment using activated sludge (Paxeus, 2004) is not effective in removing these compounds completely. The promising technology for the treatment of wastewaters containing pharmaceuticals is advanced oxidation processes (AOPs) (Dantas et al., 2011; Klavarioti et al., 2009). These techniques are based on the generation of hydroxyl radicals, which oxidize and mineralize all the organic compounds. Among AOPs, photocatalysis is an effective, low cost, environmental friendly and sustainable treatment technique. This process is based on the interaction of light and a semiconductor (catalyst). The most effective photocatalyst for this purpose is titanium dioxide (TiO2) (Malato et al., 2002). A photon with energy higher than TiO2 band gap (3.2 eV for anatase and 3.0 eV for rutile) arrives to the catalyst surface, an electron is photo excited from the valence to the conduction band; the wavelength range with energy higher than TiO2 band gap is λ < 390 nm. This mechanism generates electron–hole pairs on the semiconductor surface which lead to a chain of redox reactions related to organic contaminants degradation (Fig. 2) (Chong et al., 2010). The photocatalytic oxidation of an organic species often proceeds via adsorption of the contaminant on the surface of the catalyst, followed by direct subtraction of the contaminant’s electrons by positively charged holes. Another possible way is oxidation with OH radicals, generated from water of the aqueous environment, which takes place at the catalyst surface or in its vicinity. Both reactions may proceed simultaneously and which mechanism dominates depends on the chemical and adsorption properties of the contaminant. This review article provides an overview of different photocatalytic procedures found in the literature for the abatement of β-blockers in the aquatic environment.

Principles of photocatalysis using TiO2.
Figure 2
Principles of photocatalysis using TiO2.

2

2 Photocatalytic works on β-blockers

Yang et al. (2010) performed photocatalytic degradation kinetics of three β-blockers (atenolol, metoprolol and propranolol) in aqueous solution using Pyrex reactor. The light source used was high pressure mercury lamp and the photocatalyst was Degussa P25 (commercial TiO2 powder). The three drugs were completely degraded within 40 min irradiation, using a TiO2 concentration of 2.0 g/L. The degradation of the three drugs followed pseudo-first-order kinetics and degradation occurred mainly on the surface of TiO2 by oxidation reactions with photohole (h+) or OH radicals. Degradation intermediates were completely mineralized to CO2 and nitrogen (predominantly as NH3/NH4+) within 240 min. The major degradation pathways for the three β-blockers were cleavage of side chain (–CH (OH) CH2 NH CH (CH3)2) and addition of –OH group to the parent compound. General scheme of degradation pathways for β-blockers is shown in Fig. 3 (Yang et al., 2010).

General scheme of degradation pathways for β-blockers (Yang et al., 2010).
Figure 3
General scheme of degradation pathways for β-blockers (Yang et al., 2010).

Ioannou et al. (2011) investigated decomposition of β-blockers (atenolol and propranolol) by means of TiO2 photocatalysis using solar simulator in water and wastewater. Irradiation was provided by a 1 Kw Xe-OP lamp and photocatalyst used was Degussa P25. Different commercially available TiO2 catalysts (Degussa P25, Hombicat UV100, Aldrich, Tronox AK-1, Tronox TRHP-2, Tronox TR) were used in the study and found that Degussa P25 is showing higher photocatalytic activity. This is due to its structure which is a mixture of anatase and rutile, and slower electron/hole recombination on the surface of Degussa P25. After 120 min of irradiation with Degussa P25 80% of the drug was decomposed. Degradation was favored in pure water compared with the wastewater because the latter contains dissolved organic carbon (DOC) and radical scavengers which show detrimental effect on conversions.

Toxicity of atenolol and propranolol before and after the photocatalytic treatment was evaluated by using Daphnia magna. Toxicity increased during the early stages of photocatalytic treatment for either substrate and then gradually decreased on prolonged treatment due to elimination of the substrate and its toxic reaction intermediates.

Ji et al. (2013) investigated photocatalytic degradation of atenolol in pH 6.8 Milli-Q water and river water using TiO2 as catalyst. Efficiency of the four different TiO2 catalysts (Hombicat UV100, Millennium PC500, Aldrich rutile and Degussa P25) was also investigated. Degussa P25 exhibited the highest photocatalytic activity. Complete degradation of atenolol was obtained after 60 min and 180 min of irradiation in pH 6.8 Milli-Q water and river water, respectively. Atenolol was degraded to 3-(isopropylamino)propane-1,2-diol, p-hydroxyphenylacetamide and 4-[2-hydroxy-3-(isopropylamino)propoxy] benzaldehyde through ether chain cleavage, hydroxylation and loss of CONH2 from acetamide function group respectively. Hydroxy radical (HO) was the predominant reactive species involved in the photocatalytic degradation of atenolol. Possible photocatalytic degradation pathways of atenolol are shown in Fig. 4. Intermediates formed during the photocatalysis further oxidized to five carboxylic acids namely oxalic, glyoxylic, malonic, oxamic and formic acid. In the river water atenolol degradation was slow due to the presence of inorganic ions and natural radical scavengers (Cl, CO32−, HCO3 and dissolved organic matter). Inorganic ions compete for the active sites on the TiO2 surface or they form salt layer on the TiO2 surface and reducing/blocking the accessibility of catalyst and substrate (atenolol). Natural radical scavengers present in the river water reduce the HO concentration and thereby decreasing the photocatalytic efficiency.

Photocatalytic degradation pathways for atenolol in aqueous TiO2 suspensions (Ji et al., 2013).
Figure 4
Photocatalytic degradation pathways for atenolol in aqueous TiO2 suspensions (Ji et al., 2013).

Romero et al. (2011) investigated the degradation of metoprolol and propranolol by photocatalysis. Photocatalytic experiments were carried out with 0.4 g/L of TiO2 as catalyst, 50 mg/L of both drugs and xenon lamp as irradiation source. Metoprolol and propranolol were completely removed after 300 and 360 min of irradiation, respectively. Biodegradability and toxicity tests were performed to assess the suitability of the photocatalytic treatment. Untreated samples were not biodegradable and treated samples were biodegradable through oxidation promoted by hydroxyl radicals. Biodegradability of the metoprolol was faster compared with the propranolol. Acute toxicity of both compounds prior and after the treatment was determined by measuring the inhibition of Vibrio fischeri bioluminescence. Toxicity of the metoprolol was reduced from the beginning of the treatment but for propranolol more toxic intermediates than the primary compound were formed in the early-stage of reaction, after 30 min of irradiation, the toxicity was decreased continuously.

De la cruz et al. (2013) assessed the propranolol degradation by direct photolysis and TiO2 photocatalysis using solar and artificial (Xe-lamp) light. In this study photo-reactors made with quartz and Duran were tested and found that quartz reactor given significant propranolol degradation. In the direct photolysis, after 240 min of irradiation 77% and 71% of the drug was degraded by the solar plant and the laboratory device (artificial light), respectively. Mineralization observed was 7% in the solar plant and 2% in the laboratory device.

In the photocatalysis treatment, concentration of TiO2 used was 0.4 g/L and the degradation observed after 240 min of irradiation was 81% for the solar plant and 94% for lab device. Meanwhile mineralization reached was 30% and 41% in solar plant and laboratory device, respectively.

This study shown that photocatalysis is better than the photolysis in the propranolol degradation and mineralization. Mineralization was negligible in the photolysis compared with the photocatalysis because there are no other photosensitive compounds in water to generate hydroxyl radicals which are main reactive species for propranolol removal.

Rivas et al. (2010) investigated the efficiency of several UV-C radiation based methods for the mineralization of metoprolol. Mineralization was performed by means of UV-C, UV-C/H2O2, UV-C/percarbonate, UV-C/monopersulphate, UV-C/TiO2, UV-C/H2O2/TiO2 and photo-Fenton (Fe2+ and H2O2) reagent. Under UV-C radiation mineralization degree was negligible; addition of free radical promoters/photocatalysts significantly increases the degradation rate. Among the tested systems photo-Fenton reagent showed maximum efficiency (70% mineralization) due to three simultaneous actions in the process, direct photolysis, H2O2 photolysis and Fenton’s reagent.

Czech and Rubinowska (2013) investigated the photocatalytic degradation of metoprolol in the tube reactor using four different commercially available TiO2 samples (TiO2-Tytanpol (T1), TiO2-Sigma–Aldrich (T2), Hombikat-Sigma–Aldrich (T3) and TiO2-S21-Sigma–Aldrich (T4)) differed in specific surface area, pore volume and rutile presence. Brunauer–Emmett–Teller (BET) surface areas (m2/g) of T1, T2, T3 and T4 were 12.08, 11.50, 61.03 and 55.33, respectively. Metoprolol was most effectively removed by T3 and least effectively by T2. This study indicates that photocatalyst with highest BET surface area (T3) revealed the highest activity and lowest BET surface area (T2) revealed the lowest activity in metoprolol photocatalytic oxidation.

Ji et al. (2012) investigated the nitrate-induced photolysis behavior of atenolol and toxicity of its degradation products. Photolysis experiments were conducted under simulated solar irradiation using 1000 W Xe arc lamp. Influence of pH, bicarbonate concentration and dissolved organic matter (DOM) was also studied. Increase in the nitrate concentration increases the rate of reaction due to generation of hydroxyl radicals upon irradiation of nitrate solution.

Increase in pH decreases the reaction rate of atenolol by decreasing the rate of generation of hydroxyl radicals during irradiation of nitrate. Increase in bicarbonate concentration decreases the photodegradation rate of atenolol due to increase in pH and hydroxyl radical scavenging effect.

The presence of DOM decreases the photolysis rate constant; this is due to competition between DOM and nitrate ions for the photons. Less number of photons is available for exciting nitrate and thereby decreased the generation of hydroxyl radicals. During the photocatalysis process atenolol and its degradation products were monitored by HPLC and LC–MS. The major pathways of atenolol degradation were hydroxylation and side chain cleavage .The toxicity of the phototransformation products was evaluated by using Daphnia magna and the results revealed that they are less toxic. This study suggested that photodegradation was an important pathway for atenolol toxicity reduction in natural water containing relatively high concentration of nitrate.

Rey et al. (2012) prepared and characterized a TiO2 magnetic activated carbon catalyst to mineralize metoprolol tartrate. The photocatalytic activity of the TiO2 magnetic activated carbon catalyst was tested by performing degradation of metoprolol (Initial Concentration: 10 and 50 mg/L) under simulated solar photocatalytic ozonation. The results obtained were compared with those obtained from the experiments of single adsorption (i.e., absence of radiation and ozone), single ozonation (i.e., absence of radiation and catalyst), catalytic ozonation (i.e., absence of radiation), photolytic ozonation (i.e., absence of catalyst), TiO2 photocatalysis (i.e., absence of ozone) and photocatalytic ozonation with Degussa P25. Among the tested experimental conditions photocatalytic ozonation with Degussa P25 or TiO2 magnetic activated carbon catalyst shown higher metoprolol removal rate and total organic carbon (TOC) degradation (mineralization) due to the production of large number of hydroxyl radicals. It was observed that efficiency of TiO2 magnetic activated carbon catalyst was somewhat lower than that of the Degussa P25, even though, the prepared catalyst is an interesting alternative material for photocatalysis due to its stability and reusability. Photolytic ozonation was also equally effective that of photocatalytic ozonation when using a metoprolol initial concentration of 10 mg/L, this result provides a new way, solar photolytic ozonation for the degradation of emerging contaminants from water.

Abramovic et al. (2011) investigated the photocatalytic degradation of metoprolol tartrate in suspensions of two TiO2-based photocatalysts (Degussa P25 or Wackherr) with different surface area. TiO2 Wackherr has 6 times less surface area than Degussa P25. Faster degradation was observed with TiO2 Wackherr compared to Degussa P25 due to lesser radiation scattering and slower back reactions, which compensate the lower surface area of TiO2 Wackherr. In case of Degussa P25 slower initial degradation rate was observed due to higher radiation scattering and back reactions. After 240 min of irradiation metoprolol was mineralized completely in both the cases. Degradation intermediates were detected and identified by LC–DAD and LC–MS/MS techniques. Major degradation pathways involved in the photocatalysis of metoprolol are hydroxylation of the aromatic ring, shortening of the methoxyl-containing lateral chain and cleavage of, or addition of hydroxyl radical to, the amine-containing chain.

Santiago-Morales et al. (2013) studied visible light photocatalytic degradation of propranolol using cerium doped titanium dioxide as catalyst in ultrapure water and biologically treated wastewater. Cerium doping of TiO2 increases the photocatalytic efficiency of TiO2 by shifting its absorption from near UV region of the solar spectrum to the visible region. Photocatalysis of propranolol was carried out in a Duran tubular photoreactor with the concentration of 25 mg/L and radiation source is Xe-OP lamp with a photon flux of (6.19 ± 0.20) × 10−6 Einstein/s (290–400 nm). Propranolol was completely disappeared in less than 2 h of irradiation. Photocatalytic rate was less in biologically treated wastewater compared with ultrapure water due to the presence of radical scavengers and competing substances. More than thirty reaction intermediates were formed during the process and those were detected by liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (LC-ESI-QTOF-MS/MS). The major degradation pathways of the propranolol are cleavage of the ether bond and addition of hydroxyl groups to the aromatic nuclei or to the ring opening attack of hydroxyl radicals on the naphthol moiety. The toxicity of the degradation products was determined using the green algae Pseudokirchneriella subcapitata and the marine bacterium Vibrio fischeri. Multigenerational toxicity was assessed by measuring the growth inhibition of P. subcapitata and acute toxicity was evaluated by measuring the decrease in the constitute bioluminescence of V. fischeri. Toxicity study revealed that, degradation of propranolol in ultrapure water showed toxicity in the early stage of irradiation treatment due to accumulation of transformation products but in case of propranolol spiked wastewater toxicity was not observed due to lower rate of oxidation.

Chen et al. (2011) investigated the photodegradation of propranolol by Fe(III)–citrate complexes and effect of metal ions (Ca2+, Mg2+, Mn2+ and Cu2+) and humic substances on the photoreactivity of Fe(III)–citrate complexes. Fe(III)–citrate complexes are excellent photocatalysts by generation of hydroxyl radicals, which are main reactive oxygen species responsible for the photodegradation of propranolol. Metal ions inhibited the photodegradation of propranolol by competitive complexation with Fe(III) for citrate and the inhibition effect was in the order of Mn2+ > Cu2+ > Ca2+ > Mg2+. The presence of humic substances also suppressed the photodegradation of propranolol by competitive complexation of humic substances with citrate for Fe(III). The photolysis experiments were performed in Pyrex vessel under 150-W Xenon Short Arc Lamp and the degradation products formed were identified by GC–MS. 4-hydroxypropranolol, naphthalen-1-ol, 1,5-dihydroxy-naphthalene, 1,6-dihydroxy-naphthalene, some benzene series compounds, and low-molecular-weight carboxylic acids were formed upon photodegradation of propranolol in Fe(III)–citrate system. The proposed pathways for the Fe(III)–citrate-induced photodegradation of propranolol are shown in Fig. 5 (Chen et al., 2011).

The proposed pathways for the Fe(III)-citrate-induced photodegradation of propranolol (Chen et al., 2011).
Figure 5
The proposed pathways for the Fe(III)-citrate-induced photodegradation of propranolol (Chen et al., 2011).

Golubović et al. (2013) investigated the efficiency of sol–gel synthesized mesoporous TiO2 nanopowders for photocatalytic degradation of metoprolol. Mesoporous TiO2 nanopowders have been synthesized by using titanium tetrachloride (TiCl4) as the precursor. The photocatalytic efficiency of the mesoporous TiO2 was compared with Degussa P25 and effect of calcination time (1–7 h) on photocatalytic activity of mesoporous TiO2 was investigated. The mesoporous TiO2 samples calcined for 4 h have displayed higher photocatalytic performance compared with other calcination time samples due to greater mean pore diameter and the pore structure complexity. Samples calcined for 4 and 5 h have displayed higher photocatalytic performance compared with Degussa P25, whereas the sample calcined for 3 h has shown similar activity. This study indicated that, photocatalytic degradation of metoprolol was strongly effected by pore size and morphology of TiO2 nanopowders.

An overview of the works published on the photocatalysis of β-blockers is presented in Table 1.

Table 1 Summary of the works published on the photocatalysis of β-blockers.
β-Blocker Matrix Initial concentration Catalyst Irradiation source Analytical Methods % removal References
Metoprolol Distilled water 0.05 mM Degussa P25 (1.0 mg/mL), TiO2 Wackherr (1.0 mg/mL) UV HPLC, TOC, HPLC/MS–MS Complete in 30 min for TiO2 Wackherr and 60 min for Degussa P25 Abramovic et al. (2011)
Propranolol Deionized water 0.00002 M Fe(III)–citrate complex 150 W xenon short arc lamp HPLC, GC–MS 50 in 37 min Chen et al. (2011)
Metoprolol Water 50 mg/dm3 T1, T2, T3 and T4 UV lamp (254 nm, 0.7 Kw) UV–Vis spectroscopy COD 50 in 120, 145, 210 and 113 min for T1,T2, T3 and T4, respectively Czech and Rubinowska (2013)
Propranolol Milli-Q water 50 mg/L Degussa P25 (0.4 g/L) 1 Kw Xe-OP lamp, Sun light HPLC, TOC, BOD5, COD, Toxicity bioassay by Chlorella vulgaris 81 for sun light and 94 for Xe-lamp in 240 min De la cruz et al. (2013)
Metoprolol Water 0.05 mM Mesoporous TiO2 nanopowder (1 mg/cm3) UV HPLC Complete in 60 min Golubovic et al. (2013)
Atenolol propranolol Pure water and treated municipal water 5–30 mg/L Degussa P25 (50–3000 mg/L) 1 Kw Xe-OP lamp Spectrophotometer, TOC, Toxicity bioassay by D. magna 80 in 120 min Ioannou et al. (2011)
Atenolol pH 6.8 Milli-Q water and river water 37.6 μM Degussa P25 (2.0 g/L) High pressure mercury lamp (Emax = 365 nm) HPLC, TOC, HPLC/MS–MS Complete in 60 and 180 min in pH 6.8 Milli-Q water and river water, respectively Ji et al. (2013)
Atenolol Milli-Q water 40 μM Sodium nitrate (5 mM) 1000 W Xe arc lamp HPLC, TOC, HPLC/MS–MS, Toxicity bioassay by D. magna 72 in 240 min Ji et al. (2012)
Metoprolol Aqueous solution 50 mg/L Titania – coated magnetic activated carbon 1500 W xenon arc lamp (λ > 300 nm, 550 W/m2) HPLC, TOC Complete in 3 h Rey et al. (2012)
Metoprolol Aqueous solution 0.0001 M Degussa P25 Low pressure mercury lamp (Emax = 254 nm) HPLC, TOC 30 for UV-C/1 g/L TiO2 system and 45 for UV-C/ 0.001 M H2O2/ TiO2 (0.25–2.0 g/L) system in 180 min Rivas et al. (2010)
Metoprolol propranolol Milli-Q water 50 mg/L Degussa P25 (0.4 g/L) 1 Kw Xe-OP lamp HPLC, TOC, BOD5, COD, Toxicity bioassay by Vibrio fischeri Complete in 300 min for metoprolol and 360 min for propranolol Romero et al. (2011)
Propranolol Ultrapure water, biologically treated wastewater 25 mg/L Ce-doped TiO2 (cerium loading of 0.5 wt.% and bulk catalyst concentration of 0.14 g/L) 1 Kw Xe-OP lamp HPLC, TOC, COD, Toxicity bioassay by P. subcapitata and Vibrio fischeri Complete in 90 min in pure water and 360 min in wastewater Santiago-Morales et al. (2013)
Atenolol Metoprolol Propranolol Milli-Q water 100 μM Degussa P25 (2.0 g/L) High pressure mercury lamp (Emax = 365 nm) HPLC, TOC, HPLC/MS–MS Complete in 40 min Yang et al. (2010)

Abbreviations:

HPLC-MS/MS: High performance liquid chromatography-tandem mass spectrometry.

TOC: Total organic carbon.

BOD5: Biochemical oxygen demand.

COD: Chemical oxygen demand.

3

3 Summary

In recent years, the presence of β-blockers in environmental matrices has received a special attention by the scientific community due to increasing use and limited human metabolism (Alder et al., 2010; Huggett et al., 2003; Rivas et al., 2010). After being used, they are released into sewage waste water treatment system and surface waters as metabolites as well as unchanged parent molecules. These compounds are persistent and resistant to biodegradation, accumulating in the environment. They are producing harmful effects (changes in cardiac rhythm, generation of abnormalities, inhibition of the growth of human embryonic cells or reduce mobility of spermatozoids of fish) to aquatic and terrestrial ecosystems (Cleuvers, 2005; Pomati et al., 2006).

Conventional waste water treatments such as activated sludge, granular activated carbon filtration and ozonation were not effective in the removal of these compounds (Maurer et al., 2007; Paxeus, 2004; Vieno et al., 2007) requiring the development of new efficient methodologies. Several studies have reported that AOPs appear as good alternative for the degradation of β-blockers (Andreozzi et al., 2004; Medana et al., 2008; Song et al., 2008; Ternes et al., 2002).

Photocatalysis is an example of AOPs capable of achieving complete oxidation of organic and inorganic species (Calza et al., 2006; Doll and Frimmel, 2005). The catalyst employed for almost all the photocatalytic treatment studies of β-blockers is Degussa P25. It contains 80:20 anatase:rutile shows exceptional activity. Photocatalytic performance of mesoporous TiO2 nanopowders was high due to greater surface area and optimal exposure of organic molecules to light via facilitation of diffusion of organic molecules to the active sites (Tan et al., 2011; Yu et al., 2007). Doping of TiO2 with cerium increases the photocatalytic efficiency due to shifting of its absorption from near UV region to the visible region and facile formation of labile oxygen vacancies. Stability of the TiO2 was increased by preparing TiO2 magnetic activated carbon catalyst, which is reusable. TiO2 photocatalysis with ozonation is a promising technology for degradation of drugs in the aquatic environment. In this combined process larger number of hydroxyl radicals was produced compared with single ozonation or TiO2 photocatalysis. Finally photocatalysis is an efficient and inexpensive treatment technique for the removal of β-blockers from the aquatic environment.

References

  1. , , , , , , . Photocatalytic degradation of metoprolol tartrate in suspensions of twoTiO2-based photocatalysts with different surface area. Identification of intermediates and proposal of degradation pathways. J. Hazard. Mater.. 2011;198:123-132.
    [Google Scholar]
  2. , , , , , . Fate of β-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res.. 2010;44:936-948.
    [Google Scholar]
  3. , , , , , , , , , . Effects of advanced oxidation processes (AOPs) on the toxicity of a mixture of pharmaceuticals. Water Sci. Technol.. 2004;50:23-28.
    [Google Scholar]
  4. , , , , . Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater.. 2005;122:195-204.
    [Google Scholar]
  5. , , , . Ozonation of beta-blockers: kinetic studies, identification of oxidation products and pathways. Environ. Sci. Technol.. 2009;42:10-18.
    [Google Scholar]
  6. , , , , , , . Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem.. 2006;25:2163-2176.
    [Google Scholar]
  7. , , , , , , , . Photocatalytic degradation study of diclofenac over aqueous TiO2 suspensions. Appl. Catal., B: Environ.. 2006;67:197-205.
    [Google Scholar]
  8. , , , . Effluent from bulk drug production is toxic to aquatic vertebrates. Environ. Toxicol. Chem.. 2009;28(12):2656-2662.
    [Google Scholar]
  9. , , , , , , . Photodegradation of propranolol by Fe(III)–citrate complexes: kinetics, mechanism and effect of environmental media. J. Hazard. Mater.. 2011;194:202-208.
    [Google Scholar]
  10. , , , , . Recent developments in photocatalytic water treatment technology: a review. Water Res.. 2010;44:2997-3027.
    [Google Scholar]
  11. , , , , . Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges. Chemosphere. 2009;77:351-358.
    [Google Scholar]
  12. , . Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere. 2005;59:199-205.
    [Google Scholar]
  13. , , , . Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere. 2008;73:1741-1748.
    [Google Scholar]
  14. , , . TiO2-assisted photocatalytic degradation of diclofenac, metoprolol, estrone and chloramphenicol as endocrine disruptors in water. Adsorption. 2013;19:619-630.
    [Google Scholar]
  15. , , , . Ozonation of propranolol: transformation, biodegradability, and toxicity assessment. J. Environ. Eng.. 2011;137:754-759.
    [Google Scholar]
  16. , , , , . Photolysis and TiO2 photocatalysis of the pharmaceutical propranolol: solar and artificial light. Appl. Catal., B: Environ.. 2013;130–131:249-256.
    [Google Scholar]
  17. , , . Removal of selected persistent organic pollutants by heterogeneous photocatalysis in water. Catal. Today. 2005;101:195-202.
    [Google Scholar]
  18. , , , , . Analytical methods for tracing pharmaceutical residues in water and wastewater. Trends Anal. Chem.. 2007;26:515-533.
    [Google Scholar]
  19. , , , . Ecotoxicology of human pharmaceuticals. Aquat. Toxicol.. 2006;76:122-159.
    [Google Scholar]
  20. , , , , , . Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci. Total Environ.. 2010;408:4257-4269.
    [Google Scholar]
  21. , , , , , , , , , . Improved efficiency of sol–gel synthesized mesoporous anatase nanopowders in photocatalytic degradation of metoprolol. Mater. Res. Bull.. 2013;48:1363-1371.
    [Google Scholar]
  22. , , , , . Determination of beta adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ. Pollut.. 2003;121:199-205.
    [Google Scholar]
  23. , , , . Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone Sci. Eng.. 2006;28:353-414.
    [Google Scholar]
  24. , , , , , . Solar/TiO2 photocatalytic decomposition of β-blockers atenolol and propranolol in water and wastewater. Sol. Energy. 2011;85:1915-1926.
    [Google Scholar]
  25. , , , , , . Nitrate-induced photodegradation of atenolol in aqueous solution: kinetics, toxicity and degradation pathways. Chemosphere. 2012;88:644-649.
    [Google Scholar]
  26. , , , , , , , . Photocatalytic degradation of atenolol in aqueous titanium dioxide suspensions: kinetics, intermediates and degradation pathways. J. Photochem. Photobiol., A: Chem.. 2013;254:35-44.
    [Google Scholar]
  27. , , . Transparency throughout the production chain-a way to reduce pollution from the manufacturing of pharmaceuticals? Regul. Toxicol. Pharmacol.. 2009;53(3):161-163.
    [Google Scholar]
  28. , , , . Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ. Int.. 2009;35:402-417.
    [Google Scholar]
  29. , , . Kinetics and degradation products for direct photolysis of beta-blockers in water. Environ. Sci. Technol.. 2007;41:803-810.
    [Google Scholar]
  30. , , , , . Photocatalysis with solar energy at a pilot-plant scale: an overview. Appl. Catal., B: Environ.. 2002;37:1-15.
    [Google Scholar]
  31. , , , , , . Elimination of beta blockers in sewage treatment plants. Water Res.. 2007;41:1614-1622.
    [Google Scholar]
  32. , , , , , , . Characterization of atenolol transformation products on light-activated TiO2 surface by high-performance liquid chromatography/high-resolution mass spectrometry. Rapid Commun. Mass Spectrom.. 2008;22:301-313.
    [Google Scholar]
  33. , , , . Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal. Bioanal. Chem.. 2007;387:1225-1234.
    [Google Scholar]
  34. , , , , . Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography–tandem mass spectrometry. J. Chromatogr., A. 2006;1131:103-109.
    [Google Scholar]
  35. , . Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol.. 2004;50:253-260.
    [Google Scholar]
  36. , , , , , , , . Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol.. 2006;40:2442-2447.
    [Google Scholar]
  37. , , , , , . Simulated solar-light assisted photocatalytic ozonation of metoprolol over titania-coated magnetic activated carbon. Appl. Catal., B: Environ.. 2012;111–112:246-253.
    [Google Scholar]
  38. , , . The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol.. 1985;37:1-12.
    [Google Scholar]
  39. , , , , . UV-C radiation based methods for aqueous metoprolol elimination. J. Hazard. Mater.. 2010;179:357-362.
    [Google Scholar]
  40. , , , , , , . Photocatalytic treatment of metoprolol and propranolol. Catal. Today. 2011;161:115-120.
    [Google Scholar]
  41. , , , , . Pharmaceuticals in groundwaters—analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany. J. Chromatogr., A. 2001;938:199-210.
    [Google Scholar]
  42. , , , , , , , . Transformation products and reaction kinetics in simulated solar light photocatalytic degradation of propranolol using Ce-doped TiO2. Appl. Catal., B: Environ.. 2013;129:13-29.
    [Google Scholar]
  43. , , , , . Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain) J. Hazard. Mater.. 2009;164:1509-1519.
    [Google Scholar]
  44. , . Oxidative transformations of environmental pharmaceuticals by Cl2, ClO2, O3, and Fe(VI): kinetics assessment. Chemosphere. 2008;73:1379-1386.
    [Google Scholar]
  45. , , , , , . Free radical destruction of beta-blockers in aqueous solution. Environ. Sci. Technol.. 2008;42:1256-1261.
    [Google Scholar]
  46. , , , . ISRN Mater. Sci. 2011:2011.
  47. , . Occurrence of drugs in German sewage treatment plants and rivers. Water Res.. 1998;32:3245-3260.
    [Google Scholar]
  48. , , . Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management (first ed.). IWA Publishing; .
  49. , , , , , , , , , . Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol.. 2002;36:3855-3863.
    [Google Scholar]
  50. , , , , . Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol.. 2007;41:5077-5084.
    [Google Scholar]
  51. , , , , , , , . Photocatalytic degradation kinetics and mechanism of environmental pharmaceuticals in aqueous suspension of TiO2: a case of β-blockers. J. Hazard. Mater.. 2010;179:834-839.
    [Google Scholar]
  52. , , , , . Hydrothermal preparation and photocatalytic activity of hierarchically sponge-like macro-/mesoporous titania. J. Phys. Chem. C. 2007;111:10582-10589.
    [Google Scholar]
Show Sections